Atlas Trials

Safety Trial of NK Cell DLI 3-5/6 Family Member Following Nonmyeloablative ASCT

Clinical trial NCT00586703 · COMPLETED

Trial details

NCT number
NCT00586703
Sponsor
David Rizzieri, MD
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Lymphoma
Start date
2005-04-01
Primary completion
2013-04-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.